Center for Stem Cell Transplantation and Immunotherapy

Programs and services

  • JACIE accredited adult and pediatric stemm cell transplant programs
  • Autologous and allogeneic stem cell transplantation (>250 stem cell transplants/year)
  • Indications: Acute Leukemia (AML, ALL), ­Myeloproliferative syndromes (Myelofibrosis),
  • Malignant lymphomas, Hodgkin’s disease, SAA, myelodysplasia (MDS), Multiple Myeloma, immunodeficiencies inborn hematologic disorders (thalassemia, sickle cell disease etc.)
  • Cord blood transplantation
  • Haploidentical stem cell transplantation (coordination of an international trial for haplo-SCT)
  • Adoptive Immunotherapy: Antibodies, novel antibody constructs (IgM/bi/tri-specific antibodies) for AML / ALL / NHL / Multiple Myeloma)
  • T Cell Therapy, DC vaccination to treat viral, ­fungal infection, relapse, CAR-modified T cells
  • DC vaccination program for solid tumors (CNS tumors, HIT-HGG Rez Immunovac trial)
  • EU-projects for Multiple Myeloma (OPTATIO), GvHD (NanoII), Tumor- and Infection-control post-transplant (T-Control)
  • BMBF projects for the treatment of fungal/viral infection

Cooperating institutions

  • Department of Internal Medicine II
  • Department of Pediatrics
  • GMP Stem Cell Laboratory
  • Department of Radiation Oncology
  • Institute for Transfusion Medicine and ­Haemotherapy
  • Institute for Hygiene and Microbiology
  • Institute for Virology and Immunology